Diagnostic Tests Market by Companies, Growth, Competitors Analysis, New Technology and Forecast by 2029
Global Diagnostic Tests Market – Industry Trends and Forecast to 2029
Global Diagnostic Tests Market Analysis and Size
In recent years, the need for diagnostic tests have rapidly increased owing to the emergence of various diseases and infections. The rise in the investment for diagnostic tests is escalating the growth of diagnostic tests market.
- Global diagnostic tests market was valued at USD 162,456.67 million in 2021 and is expected to reach USD 339,892.97 million by 2029, registering a CAGR of 9.00% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Global Diagnostic Tests Market Definition
Diagnostic tests refer to the type of medical tests that are performed to aid in the detection or diagnosis of any disease. These tests have a crucial role in the control, surveillance and prevention of any disease. These type of tests in enhancing patient care, consumer safety, and reducing healthcare spending.
Competitive Landscape and Diagnostic Tests Market Share Analysis
The diagnostic tests market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to diagnostic tests market.
Some of the major players operating in the diagnostic tests market are:
- F-Hoffman La-Rcohe Ltd. (Switzerland)
- ABBOTT (US)
- Danaher (US)
- BD (US)
- Thermo Fisher Scientific Inc. (US)
- ACON Laboratories Inc. (US)
- Hemosure, Inc. (US)
- MicroGen Diagnostics (US)
- QIAGEN (Germany)
Comments
Post a Comment